京東(09618.HK)與科大訊飛達成戰略合作
京東集團(09618.HK)(JD.US)宣布近日與科大訊飛(002230.SZ)簽訂戰略合作協議,雙方將在數字城市和數字經濟、雲服務、零售消費者業務、智慧物流、企業及員工服務等領域展開深入探討與合作。
京東表示,未來將與科大訊飛在共同推進數字政府場景突破、數字經濟領域合作、鄉村振興領域合作、工業企業數字化轉型、區域醫療健康信息化創新、教育教學決策科學化共六個方面合作拓展,捉緊住數字化轉型發展機遇,推進新型智慧城市建設步伐。
同時,雙方並將擴大在雲基礎設施及雲能力領域的技術合作,在同等條件下科大訊飛將優先使用京東雲服務。(gc/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.